POINT Biopharma Global Inc.

POINT Biopharma Global Inc., trading under the ticker RACA, is a special purpose acquisition company that completed its initial public offering in 2020 with a focus on the healthcare and biopharmaceutical sector. The company, sponsored by Research Alliance Sponsor LLC, filed a Form 10-Q with the Securities and Exchange Commission on April 29, 2021, under accession number 0001104659-21-057283, reflecting its status as a blank check company actively pursuing a business combination target in the life sciences space. RACA's radiopharmaceutical sector focus positioned it within a specialized corner of the healthcare SPAC market during a period of heightened deal activity. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time deal tracking on RACA and hundreds of other SPACs.